SureTrader SureTrader
Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

$120 per share for NAVB? Let the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
casperboo Member Profile
 
Followed By 6
Posts 1,246
Boards Moderated 0
Alias Born 02/13/10
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/27/2016 6:02:26 AM
Navidea Appoints Michael M. Goldberg, M.D. President and Chief Executive Officer "Business Wire" - 9/26/2016 5:00:00 PM
Navidea Achieves $1 Million in Lymphoseek® Commercial Milestones "Business Wire" - 9/22/2016 6:59:00 AM
Navidea’s Lymphoseek® Receives Positive Opinion in Europe for a New Reduced Mass Vial "Business Wire" - 9/16/2016 8:15:00 AM
Navidea's Lymphoseek® Receives Positive Opinion in Europe for a New Reduced Mass Vial "PR Newswire (US)" - 9/16/2016 8:15:00 AM
Navidea to Present at Upcoming Investor Conferences "Business Wire" - 9/14/2016 7:00:00 AM
Navidea Biopharmaceuticals to Hold Investor Update Call "Business Wire" - 9/6/2016 3:21:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/6/2016 8:20:50 AM
Navidea Biopharmaceuticals Enters into Letter of Intent with Cardinal Health for the Sale of Lymphoseek® in North America "Business Wire" - 9/6/2016 6:59:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/31/2016 9:30:12 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/11/2016 5:16:58 PM
Navidea Biopharmaceuticals Announces 2016 Annual Meeting Results "Business Wire" - 8/11/2016 5:00:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/11/2016 4:04:57 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) "Edgar (US Regulatory)" - 8/10/2016 3:44:00 PM
Navidea Executes a Term Sheet with Cerveau Technologies to Sublicense NAV4694 "Business Wire" - 8/8/2016 5:00:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/4/2016 7:09:42 AM
Navidea Reports Second Quarter 2016 Financial Results "Business Wire" - 8/4/2016 6:59:00 AM
Navidea Biopharmaceuticals to Announce Second Quarter 2016 Financial Results on August 4, 2016 "Business Wire" - 7/28/2016 10:15:00 AM
Navidea Receives IRB Approval for its Lymphoseek® Rheumatoid Arthritis Clinical Trial Protocol "Business Wire" - 7/19/2016 6:59:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/18/2016 5:14:23 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/7/2016 4:45:14 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/7/2016 4:44:08 PM
Why Investors Love These Biotech's Stocks? - XOMA Corp., Navidea Biopharma, Radius Health, and Cara Therapeutics "PR Newswire (US)" - 7/5/2016 7:45:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 7/1/2016 12:26:45 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 7/1/2016 12:24:52 PM
casperboo   Saturday, 05/18/13 11:44:14 PM
Re: KnightlyCruiser post# 3713
Post # of 8907 
$120 per share for NAVB? Let the good Lord hear ya!

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist